StonvexLoading…
StonvexStonvexStonvexCore line items from ENS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2025 2025-12-28 | Q3 2025 2025-09-28 | Q2 2025 2025-06-29 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $2.76B | $1.84B | $893.02M | $3.62B |
Operating Income | $302.76M | $178.51M | $86.48M | $464.69M |
Net Income | $216.26M | $125.88M | $57.46M | $363.74M |
EPS (Diluted) | $5.65 | $3.26 | $1.46 | $8.99 |
Total Assets | $4.05B | $4.07B | $4.11B | $3.97B |
Total Liabilities | $2.15B | $2.21B | $2.24B | $2.05B |
Cash & Equivalents | $450.08M | $388.61M | $346.66M | $343.13M |
Free Cash Flow OCF − CapEx | $336.36M | $165.09M | $-32.05M | $139.26M |
Shares Outstanding | 36.73M | 37.20M | 37.46M | 39.19M |